Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Characterization of AmpC ß-lactamase mutations of extensively drug-resistant Pseudomonas aeruginosa isolates that develop resistance to ceftolozane/tazobactam during therapy
Marta Fernández-Esgueva; Ana Isabel López-Calleja; Xavier Mulet; Pablo A. Fraile-Ribot; Gabriel Cabot; Rafael Huarte; Antonio Rezusta; Antonio Oliver;
Enferm Infecc Microbiol Clin. 2020;38:474-8
Evaluation of three commercial methods of susceptibility testing for ceftolozane/tazobactam against carbapenem-resistant Pseudomonas aeruginosa
Lorena López-Cerero; Sofia Ballesta; Cristina Elías López; Waldo Sánchez-Yebra; María Dolores Rojo-Martin; Alvaro Pascual;
Enferm Infecc Microbiol Clin. 2023;41:621-4
What's new in mechanisms of antibiotic resistance in bacteria of clinical origin?
Alejandra Asenjo; Jesús Oteo-Iglesias; Juan-Ignacio Alós;
Enferm Infecc Microbiol Clin. 2021;39:291-9